Your browser doesn't support javascript.
loading
Risk factors for postoperative nausea and vomiting after video-assisted thoracic surgery esophagectomy: a prospective cohort study.
Muraoka, K; Sato, M; Yonezawa, R; Kurihara, T; Higuchi, S; Kogo, M.
Afiliación
  • Muraoka K; Division of Pharmacotherapeutics, Department of Clinical Pharmacy, Showa University Graduate School of Pharmacy, Tokyo, Japan.
  • Sato M; Department of Pharmacy, Showa University Hospital, Tokyo, Japan.
  • Yonezawa R; Department of Hospital Pharmaceutics, Showa University School of Pharmacy, Tokyo, Japan.
  • Kurihara T; Department of Clinical Pharmacy, Showa University School of Pharmacy, Tokyo, Japan.
  • Higuchi S; Department of Hospital Pharmaceutics, Showa University School of Pharmacy, Tokyo, Japan.
  • Kogo M; Department of Pharmacy, Showa University Fujigaoka Hospital, Yokohama, Tokyo, Japan.
Pharmazie ; 79(1): 17-23, 2024 Feb 29.
Article en En | MEDLINE | ID: mdl-38509627
ABSTRACT
Video-assisted thoracic surgery esophagectomy (VATS-E) may increase the risk of postoperative nausea and vomiting (PONV) because it uses a high dosage of anesthesia through a long operative duration. However, no study has examined the risk factors for PONV after VATS-E. Therefore, we investigated the risk factors for PONV to support the appropriate risk management of PONV after VATS-E. This prospective cohort study included 155 patients who underwent VATS-E at the Showa University Hospital between April 1st, 2020 and November 30th, 2022. The primary outcome was the incidence of PONV within 24 h after surgery. Significant independent risk factors associated with the incidence of PONV were selected using multivariate analysis. The association between the number of risk factors for PONV and incidence of PONV was analyzed. One-hundred fifty-three patients were included in the analysis. The patients' median age was 67 years (range, 44-88), and 79.1% were male. PONV occurred in 35 (22.9%) patients. In the multivariate analysis, remifentanil dosage > 89.0 ng/kg/ min, albumin ≤ 3.5 g/dL, and eGFR < 60 mL/min/1.73 m 2 were independent significant risk factors for PONV. A significant association was observed between the incidence of and the number of risk factors for PONV (0 factor, 5.8%; 1 factor, 27.3%; ≥ 2 factors, 40.0%; p = 0.001). These three risk factors are useful indicators for selecting patients at high risk of developing PONV after VATS-E. In these patients, avoiding the development of PONV will be possible by performing appropriate risk management.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Náusea y Vómito Posoperatorios / Cirugía Torácica Asistida por Video Límite: Aged / Female / Humans / Male Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Náusea y Vómito Posoperatorios / Cirugía Torácica Asistida por Video Límite: Aged / Female / Humans / Male Idioma: En Año: 2024 Tipo del documento: Article